In view of all the above results, and the fact that BRAF mutations occur at higher incidence in the context of proximal colon cancers characterized by the CIMP-H phenotype1, we focused our studies to determine the impact of loss of genes subject to frequent silencing by promoter hypermethylation in proximal CIMP-H cancers. This evidence concerns the gene BRAF and malignant colon neoplasm.